CASI Pharmaceuticals (CASIF) Goodwill & Intangibles (2021 - 2025)

CASI Pharmaceuticals (CASIF) has 5 years of Goodwill & Intangibles data on file, last reported at $2.5 million in Q4 2025.

• Quarterly Goodwill & Intangibles rose 0.57% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.5 million (up 0.57% YoY) and the FY2025 annual result came in at $2.5 million, up 0.57% from the prior year.
• Goodwill & Intangibles climbed to $2.5 million in Q4 2025, from $224000.0 in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $1.8 billion in Q4 2023 to a low of $224000.0 in Q3 2025.
• A 5-year average of $362.8 million and a median of $2.5 million in 2025 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2023 — Goodwill & Intangibles soared 172900.94% — and 2025, when it slumped 99.98%.
• Tracing CASIF's Goodwill & Intangibles over 5 years: stood at $16.0 million in 2021, then slumped by 93.37% to $1.1 million in 2022, then soared by 172900.94% to $1.8 billion in 2023, then sank by 99.87% to $2.5 million in 2024, then grew by 0.57% to $2.5 million in 2025.
• The last three Goodwill & Intangibles figures came in at $2.5 million (Q4 2025), $224000.0 (Q3 2025), and $230000.0 (Q2 2025), per Business Quant data.